Paper36926709
Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity.
Ahmed Z. Neural Regen Res, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity. Papers, record 36926709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36926709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19631747 | Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. | Neurobiol Dis | 2009 | https://conductscience.org/library/papers/19631747 | PubMed |
| 2 | 17318226 | Matrix metalloproteinases and the regulation of tissue remodelling. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17318226 | PubMed |
| 3 | 18264108 | Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. | Nat Med | 2008 | https://conductscience.org/library/papers/18264108 | PubMed |
| 4 | 21624491 | Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trial. | Pulm Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21624491 | PubMed |
| 5 | 22198278 | Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential. | Nat Med | 2011 | https://conductscience.org/library/papers/22198278 | PubMed |
| 6 | 11923444 | NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. | J Neurosci | 2002 | https://conductscience.org/library/papers/11923444 | PubMed |
| 7 | 11567062 | Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. | J Neurosci | 2001 | https://conductscience.org/library/papers/11567062 | PubMed |
| 8 | 22853439 | Neuroprotective effects of sulforaphane after contusive spinal cord injury. | J Neurotrauma | 2012 | https://conductscience.org/library/papers/22853439 | PubMed |
| 9 | 18511041 | Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. | Exp Neurol | 2008 | https://conductscience.org/library/papers/18511041 | PubMed |
| 10 | 14689443 | The TIMPs tango with MMPs and more in the central nervous system. | J Neurosci Res | 2004 | https://conductscience.org/library/papers/14689443 | PubMed |
| 11 | 8958220 | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8958220 | PubMed |
| 12 | 10998420 | Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10998420 | PubMed |
| 13 | 11095516 | Metalloproteinase increases in the injured rat spinal cord. | Neuroreport | 2000 | https://conductscience.org/library/papers/11095516 | PubMed |
| 14 | 34491542 | Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis. | Pain Ther | 2021 | https://conductscience.org/library/papers/34491542 | PubMed |
| 15 | 27377304 | Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury. | Spinal Cord | 2017 | https://conductscience.org/library/papers/27377304 | PubMed |
| 16 | 12196576 | Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. | J Neurosci | 2002 | https://conductscience.org/library/papers/12196576 | PubMed |
| 17 | 11687497 | How matrix metalloproteinases regulate cell behavior. | Annu Rev Cell Dev Biol | 2001 | https://conductscience.org/library/papers/11687497 | PubMed |
| 18 | 19712708 | To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/19712708 | PubMed |
| 19 | 17217414 | Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. | J Neurochem | 2007 | https://conductscience.org/library/papers/17217414 | PubMed |
| 20 | 18848143 | Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection. | J Am Coll Cardiol | 2008 | https://conductscience.org/library/papers/18848143 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40822305 | Localised delivery of interleukin-13 from a PLGA microparticle embedded GelMA hydrogel improves functional and histopathological recovery in a mouse contusion spinal cord injury model. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40822305 | PubMed |
| 39470872 | Mechanisms and Therapeutic Prospects of Microglia-Astrocyte Interactions in Neuropathic Pain Following Spinal Cord Injury. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39470872 | PubMed |
| 38792314 | Spinal Cord Injury Management Based on Microglia-Targeting Therapies. | J Clin Med | 2024 | https://conductscience.org/library/papers/38792314 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP12 | 4321 | PubTator's text mining | https://conductscience.org/library/genes/4321 | NCBI Gene |
| MMP13 | 4322 | PubTator's text mining | https://conductscience.org/library/genes/4322 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP8 | 4317 | PubTator's text mining | https://conductscience.org/library/genes/4317 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36926709
GET https://conductscience.org/api/papers/v1/36926709/references?page=2